President Trump made a lot of promises on the campaign trail last year. Investors and business leaders enthusiastically cheered some, like lower taxes and relaxed regulation, and expressed wariness about others, like tariffs and reduced immigration. But when Mr. Trump won the election, there was little sign of that ambivalence: Stock prices soared, as did…
In Washington, many protesters declined to share their names publicly, for similar reasons. One woman, who wore a surgical mask and a long, white lab coat with the words “Mad Scientist” on the back in red lettering, described herself only as a federally funded researcher “who’s trying to keep things moving forward in these challenging…
Comments from a member of President Trump’s cabinet over the weekend have renewed concerns that the new administration could seek to interfere with federal statistics — especially if they start to show that the economy is slipping into a recession. In an interview on Fox News on Sunday, Howard Lutnick, the commerce secretary, suggested that…
Even by Washington standards, the second Trump presidency has begun in frenetic fashion: mass firings at federal agencies, tariff threats against allies and foes alike, and haggling over how to get a Republican budget through a narrowly divided Congress. Business leaders and corporate investors are confident that things will turn out fine, at least for…
As the reality sets in that the United States is drastically diminishing its foreign assistance to developing countries, an urgent conversation is starting among governments, philanthropists, and global health and development organizations. It is centered on one crucial question: Who will fill this gap? Last year, the United States contributed about $12 billion to global…
A federal judge ordered the Trump administration to hold off on a plan that would cut $4 billion in federal funding for research at the nation’s universities, cancer centers and hospitals. The funds disbursed by the National Institutes of Health cover the administrative and overhead costs for a vast swath of biomedical research, some of…
The 119th Congress began, as it so often has in recent years, with calls from Republican politicians for wrestling down the national debt, which is near a record level relative to the size of the economy. But this time, the G.O.P. had company: Progressive economists and budget wonks, who have often dismissed finger-wagging about debt…
President Biden ran for the White House promising to be a transitional figure, then once he got there began thinking of himself as a transformational one. But after a tumultuous four years in office, it turns out he was really neither. Instead, Mr. Biden will end up in the history books as an interregnum between…
